101 related articles for article (PubMed ID: 20125030)
1. Pharmacologic inhibition of myeloid differentiation factor 88 (MyD88) prevents left ventricular dilation and hypertrophy after experimental acute myocardial infarction in the mouse.
Van Tassell BW; Seropian IM; Toldo S; Salloum FN; Smithson L; Varma A; Hoke NN; Gelwix C; Chau V; Abbate A
J Cardiovasc Pharmacol; 2010 Apr; 55(4):385-90. PubMed ID: 20125030
[TBL] [Abstract][Full Text] [Related]
2. Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound.
Loiarro M; Capolunghi F; Fantò N; Gallo G; Campo S; Arseni B; Carsetti R; Carminati P; De Santis R; Ruggiero V; Sette C
J Leukoc Biol; 2007 Oct; 82(4):801-10. PubMed ID: 17548806
[TBL] [Abstract][Full Text] [Related]
3. Myeloid differentiation factor-88/interleukin-1 signaling controls cardiac fibrosis and heart failure progression in inflammatory dilated cardiomyopathy.
Blyszczuk P; Kania G; Dieterle T; Marty RR; Valaperti A; Berthonneche C; Pedrazzini T; Berger CT; Dirnhofer S; Matter CM; Penninger JM; Lüscher TF; Eriksson U
Circ Res; 2009 Oct; 105(9):912-20. PubMed ID: 19762681
[TBL] [Abstract][Full Text] [Related]
4. Chronic treatment with metformin suppresses toll-like receptor 4 signaling and attenuates left ventricular dysfunction following myocardial infarction.
Soraya H; Clanachan AS; Rameshrad M; Maleki-Dizaji N; Ghazi-Khansari M; Garjani A
Eur J Pharmacol; 2014 Aug; 737():77-84. PubMed ID: 24842192
[TBL] [Abstract][Full Text] [Related]
5. Targeted deletion of nuclear factor kappaB p50 enhances cardiac remodeling and dysfunction following myocardial infarction.
Timmers L; van Keulen JK; Hoefer IE; Meijs MF; van Middelaar B; den Ouden K; van Echteld CJ; Pasterkamp G; de Kleijn DP
Circ Res; 2009 Mar; 104(5):699-706. PubMed ID: 19168865
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of myeloid differentiation factor 88(MyD88) by ST2825 provides neuroprotection after experimental traumatic brain injury in mice.
Zhang HS; Li H; Zhang DD; Yan HY; Zhang ZH; Zhou CH; Ye ZN; Chen Q; Jiang TW; Liu JP; Hang CH
Brain Res; 2016 Jul; 1643():130-9. PubMed ID: 27155455
[TBL] [Abstract][Full Text] [Related]
7. Favorable left ventricular remodeling following large myocardial infarction by exercise training. Effect on ventricular morphology and gene expression.
Orenstein TL; Parker TG; Butany JW; Goodman JM; Dawood F; Wen WH; Wee L; Martino T; McLaughlin PR; Liu PP
J Clin Invest; 1995 Aug; 96(2):858-66. PubMed ID: 7635980
[TBL] [Abstract][Full Text] [Related]
8. The TIR/BB-loop mimetic AS-1 protects the myocardium from ischaemia/reperfusion injury.
Cao Z; Hu Y; Wu W; Ha T; Kelley J; Deng C; Chen Q; Li C; Li J; Li Y
Cardiovasc Res; 2009 Dec; 84(3):442-51. PubMed ID: 19586942
[TBL] [Abstract][Full Text] [Related]
9. Ventricular remodeling and angiotensin-converting enzyme inhibitors.
Goldstein S; Sabbah H
J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S27-31. PubMed ID: 7700061
[TBL] [Abstract][Full Text] [Related]
10. [Post-infarct myocardial remodelling: from experimental data to the prevention of heart failure].
Jalil JE; Corbalán R
Rev Med Chil; 1990 Oct; 118(10):1143-9. PubMed ID: 2152634
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1 trap attenuates cardiac remodeling after experimental acute myocardial infarction in mice.
Van Tassell BW; Varma A; Salloum FN; Das A; Seropian IM; Toldo S; Smithson L; Hoke NN; Chau VQ; Robati R; Abbate A
J Cardiovasc Pharmacol; 2010 Feb; 55(2):117-22. PubMed ID: 19920765
[TBL] [Abstract][Full Text] [Related]
12. High dose aspirin and left ventricular remodeling after myocardial infarction: aspirin and myocardial infarction.
Adamek A; Hu K; Bayer B; Wagner H; Ertl G; Bauersachs J; Frantz S
Basic Res Cardiol; 2007 Jul; 102(4):334-40. PubMed ID: 17340057
[TBL] [Abstract][Full Text] [Related]
13. Myeloid differentiation factor 88 is up-regulated in epileptic brain and contributes to experimental seizures in rats.
Wang N; Han X; Liu H; Zhao T; Li J; Feng Y; Mi X; Zhang Y; Chen Y; Wang X
Exp Neurol; 2017 Sep; 295():23-35. PubMed ID: 28529112
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of endogenous Mst1 prevents apoptosis and cardiac dysfunction without affecting cardiac hypertrophy after myocardial infarction.
Odashima M; Usui S; Takagi H; Hong C; Liu J; Yokota M; Sadoshima J
Circ Res; 2007 May; 100(9):1344-52. PubMed ID: 17395874
[TBL] [Abstract][Full Text] [Related]
15. [Remodeling after myocardial infarction--left ventricular dilation as potential therapeutic target].
Maczewski M
Kardiol Pol; 2005 Oct; 63(4 Suppl 2):S483-8. PubMed ID: 20527404
[TBL] [Abstract][Full Text] [Related]
16. The mechanism of LPS-induced HIV type I activation in transgenic mouse macrophages.
Kadoki M; Choi BI; Iwakura Y
Int Immunol; 2010 Jun; 22(6):469-78. PubMed ID: 20504885
[TBL] [Abstract][Full Text] [Related]
17. Molecular size hyaluronan differently modulates toll-like receptor-4 in LPS-induced inflammation in mouse chondrocytes.
Campo GM; Avenoso A; Campo S; D'Ascola A; Nastasi G; Calatroni A
Biochimie; 2010 Feb; 92(2):204-15. PubMed ID: 19879319
[TBL] [Abstract][Full Text] [Related]
18. Left ventricular remodeling following myocardial infarction.
Pfeffer MA
Cardiologia; 1994 Dec; 39(12 Suppl 1):25-6. PubMed ID: 7634276
[No Abstract] [Full Text] [Related]
19. MyD88-dependent nuclear factor-kappaB activation is involved in fibrinogen-induced hypertrophic response of cardiomyocytes.
Li T; Wang Y; Liu C; Hu Y; Wu M; Li J; Guo L; Chen L; Chen Q; Ha T; Li C; Li Y
J Hypertens; 2009 May; 27(5):1084-93. PubMed ID: 19342961
[TBL] [Abstract][Full Text] [Related]
20. Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NFκB signaling, MAPK, and Jak1/Stat1 pathways.
Gorina R; Font-Nieves M; Márquez-Kisinousky L; Santalucia T; Planas AM
Glia; 2011 Feb; 59(2):242-55. PubMed ID: 21125645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
